Investment analysts at StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a note issued to investors on Saturday. The firm set a “hold” rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Performance
Shares of Sorrento Therapeutics stock opened at $0.00 on Friday. Sorrento Therapeutics has a twelve month low of $0.00 and a twelve month high of $0.25. The company’s 50 day moving average is $0.01 and its 200 day moving average is $0.01.
About Sorrento Therapeutics
Read More
- Five stocks we like better than Sorrento Therapeutics
- Energy and Oil Stocks Explained
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- How Technical Indicators Can Help You Find Oversold StocksĀ
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- What Investors Need to Know to Beat the Market
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.